Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jodie Reider"'
Autor:
Amelia S Wallace, Alex R Chang, Jung-Im Shin, Jodie Reider, Justin B Echouffo-Tcheugui, Morgan E Grams, Elizabeth Selvin
Publikováno v:
J Clin Endocrinol Metab
Objective Obesity is a global public health challenge and strongly associated with type 2 diabetes (T2D), but its burden and effects are not well understood in people with type 1 diabetes (T1D). Particularly, the link between obesity and chronic kidn
Autor:
Jodie Reider
Publikováno v:
Endocrine Practice. 29:S74
Autor:
Aparna Baburaj, Jodie Reider
Publikováno v:
Endocrine Practice. 28:S130-S131
Autor:
Jodie Reider, Runa Acharya, Rose A. Salata, Ronald A. Codario, Neha D. Karajgikar, Mary T. Korytkowski, Amy C. Donihi, Pooja Manroa
Publikováno v:
Endocrine Practice. 25:407-412
Objective: To determine the efficacy and safety of a diabetic ketoacidosis (DKA)-Power Plan (PP) for guiding intravenous (IV) insulin infusions prior to anion gap (AG) closure and administering subcutaneous (SC) insulin ≥1 hour before discontinuing
Autor:
Jodie Reider, Morgan E. Grams, Elizabeth Selvin, Lesley A. Inker, Jung-Im Shin, Alex R. Chang
Publikováno v:
Circulation. 141
Introduction: Cardiovascular disease is a major complication among patients with diabetes, and may merit changes in both antihypertensive medications (e.g., to beta blockers and ACE inhibitors) and glucose-lowering medications (e.g., to sodium-glucos
Publikováno v:
Endocrine Practice. 27:S8-S9
Autor:
Deekchha Uprety, Jodie Reider
Publikováno v:
Endocrine Practice. 27:S54-S55
Autor:
Marilyn Augustine, Amy C. Donihi, Sandra I. Sobel, Patrick J. Forte, Jodie Reider, Mary T. Korytkowski
Publikováno v:
Endocrine Practice. 21:1269-1276
The number of people with diabetes using continuous subcutaneous insulin infusions (CSII) with an insulin pump has risen dramatically, creating new challenges when these patients are admitted to the hospital for surgical or other procedures. There is
Systemic steroids (glucocorticoids) are used ubiquitously in the hospital for a variety of indications. Although they have clear and wide-ranging benefits, they are also a major contributor to severe hyperglycemia. In patients with and without preexi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9381ab99253310a88e793607101e6f07
https://doi.org/10.2337/9781580406086.07
https://doi.org/10.2337/9781580406086.07
Publikováno v:
Polish Archives of Internal Medicine. 119:8001-809
Substantial observational data has linked hyperglycemia in hospitalized patients with poor patient outcomes. While early studies suggested improved clinical outcomes with interventions targeting near euglycemia, more recent studies have yielded incon